Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Lipton, Jeffrey Howard  [Clear All Filters]
2024
Moya TAlfaro, Salas MQueralt, Carreira ASantos, Atenafu EG, Law ADatt, Lam W, Pasic I, Kim DDong Hwan, Michelis FV, Basso INovitzky, et al. Dual T cell depletion for graft versus host disease prevention in peripheral blood haploidentical hematopoietic cell transplantation for adults with hematological malignancies. Bone Marrow Transplant. 2024.
2023
Stavi V, Desai N, Michelis FV, Kim DDong Hwan, Kumar R, Lipton JHoward, Law ADatt. Late-onset Pneumocystis jirovecii pneumonia post-allogeneic stem cell transplantation after time-dependent discontinuation of prophylaxis. Eur J Haematol. 2023.
Nampoothiri RVasudevan, Tang K, Schuh A, Lam W, Maze D, Michelis FV, Chan S, Gupta V, Kim D, Kumar R, et al. Mutational Profile, Outcomes, and Impact of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Myeloid Leukemia and Inconclusive Cytogenetic Analysis. Eur J Haematol. 2023.
2022
Nampoothiri RVasudevan, Pasic I, Law ADatt, Lam W, Chen C, Michelis FV, Kim DDong Hwan, Gerbitz A, Lipton JHoward, Kumar R, et al. Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Therapy-Related Hematologic Malignancies Developing After Multiple Myeloma. Eur J Haematol. 2022.
2020
Nampoothiri RVasudevan, Chen S, Pasic I, Al-Shaibani Z, Lam W, Michelis FV, Kim DDong Hwan, Viswabandya A, Gerbitz A, Lipton JHoward, et al. Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantation. Hematol Oncol Stem Cell Ther. 2020.
2019
Prem S, Atenafu EG, Al-Shaibani Z, Loach D, Law A, Lam W, Michelis FV, Thyagu S, Kim DDong Hwan, Lipton JHoward, et al. Low rates of acute and chronic GVHD with ATG and PTCy in matched and mismatched unrelated donor peripheral blood stem cell transplants. Eur J Haematol. 2019.
Salas MQueralt, Prem S, Atenafu EG, Law ADatt, Lam W, Al-Shaibani Z, Loach D, Kim DDong Hwan, Michelis FV, Lipton JHoward, et al. Reduced Intensity Allogeneic Stem Cell Transplant with Anti-Thymocyte globulin and Post-Transplant Cyclophosphamide in Acute Myeloid Leukemia. Eur J Haematol. 2019.